A+ | A | A- | Skip to main content |

Sensex

Nifty

USDINR

GBPINR

EURINR

Wednesday, 17 June 2026 12:00 AM EOD	Asian-Paints2737.00	Hind-Unilever2197.95	ITC290.75	Trent3101.65	Larsen-and-Toubro4206.95	M-and-M3133.15	Reliance-Industries1332.55	Tata-Steel199.00	Titan-Company4381.65	SBI1026.00	Bharat-Electron419.80	Kotak-Mah-Bank404.50	Infosys1158.10	Bajaj-Finance958.10	Sun-PharmaInds1819.95	HDFC-Bank786.80	TCS2222.60	ICICI-Bank1336.75	Power-Grid-Corpn286.35	Maruti-Suzuki13631.50	Axis-Bank1350.95	HCL-Technologies1166.45	NTPC355.40	Bharti-Airtel1875.50	Tech-Mahindra1462.00	Adani-Ports1828.10	UltraTech-Cem11369.35	Bajaj-Finserv1764.75	Interglobe-Aviat4878.30	Eternal258.50
15 mins delay SENSEX 77,155.62 [347.14]	-11.80 -0.43%	-3.20 -0.15%	-1.00 -0.34%	204.65 7.06%	21.25 0.51%	-4.65 -0.15%	4.70 0.35%	3.00 1.53%	44.55 1.03%	10.50 1.03%	12.45 3.06%	-3.60 -0.88%	14.80 1.29%	-1.25 -0.13%	19.30 1.07%	2.10 0.27%	23.75 1.08%	1.85 0.14%	1.20 0.42%	-61.35 -0.45%	-14.85 -1.09%	7.10 0.61%	-0.05 -0.01%	20.30 1.09%	15.90 1.10%	6.55 0.36%	-19.60 -0.17%	-21.75 -1.22%	38.50 0.80%	4.95 1.95%

Hot Pursuit

Scrips, which has significant changes during the market hours.

Lupin launches generic hypertension drug in the US

17-Jun-26 17:27Hrs IST

The product is bioequivalent to Edarbi of Azurity Pharmaceuticals and is indicated for the treatment of hypertension in adults to lower blood pressure.

Lupin said it is the exclusive first-to-file applicant for the product and is eligible for 180 days of generic drug exclusivity in the US market.

According to IQVIA MAT April 2026 data, Azilsartan Medoxomil Tablets had estimated annual sales of USD 53.5 million in the United States.

Lupin is a global pharmaceutical company focused on branded and generic formulations, complex generics, biotechnology products and active pharmaceutical ingredients across multiple therapeutic segments. The company's consolidated profit after tax stood at Rs 1,468.70 crore in Q4 FY26, up 87.72% from Rs 782.40 crore in Q4 FY25. Net sales rose 32.9% to Rs 7391.91 crore in Q4 FY26 from Rs 5562.2 crore in Q4 FY25.

Shares of Lupin shed 0.91% to close at Rs 2,256.25 on the BSE.

Powered by Capital Market - Live News

Attention Investor :

"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

"Contents which are exclusively for Non-Broking Products/Services, "Mutual Fund, Mutual Fund-SIP, Research reports, Insurance, etc. where the Member is just a distributor. These are not Exchange traded product and the Member is just acting as distributor. It should also state that all disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism."

A Muthoot M George Enterprise